Maze Therapeutics Inc. – Investors and Politicians Who Own It
MAZE
Investors who own it
7 tracked investors, $216.2M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
David KroinDeep Track Capital, Q2 2026 | $111.4M | 1.62% |
| $41.4M | 0.04% | |
Farallon Capital ManagementQ2 2026 | $33.1M | 0.15% |
Zhang LeiHHLR Advisors (Hillhouse), Q2 2026 | $10.9M | 1.31% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $10.1M | 0.46% |
Rod WongRTW Investments, Q2 2026 | $6.3M | 0.05% |
Anand ParekhAlyeska Investment Group, Q2 2026 | $3M | 0.01% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| David Kroin | Reduced −18% | 3,477,562 |
| Farallon Capital Management | New | 373,000 |
| Zhang Lei | Reduced −20% | 366,028 |
| Daniel Schneeberger | Reduced −72% | 50,095 |
| Anand Parekh | Reduced −49% | 100,000 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.